166 related articles for article (PubMed ID: 38448251)
1. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
2. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
3. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
4. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
[TBL] [Abstract][Full Text] [Related]
5. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract][Full Text] [Related]
6. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
[TBL] [Abstract][Full Text] [Related]
7. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.
Bowen A; Gómez-Trillos S; Curran G; Graves KD; Sheppard VB; Schwartz MD; Peshkin BN; Campos C; Garcés N; Dash C; Aburto L; Valencia-Rojas N; Hernández G; Villa A; Cupertino P; Carrera P; Hurtado-de-Mendoza A
J Genet Couns; 2023 Oct; 32(5):965-981. PubMed ID: 37062905
[TBL] [Abstract][Full Text] [Related]
8. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
Bellcross CA
Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
[TBL] [Abstract][Full Text] [Related]
9. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
Appel SJ; Cleiment RJ
J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154
[TBL] [Abstract][Full Text] [Related]
10. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
Werner-Lin A; Ratner R; Hoskins LM; Lieber C
J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
[TBL] [Abstract][Full Text] [Related]
11. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
[TBL] [Abstract][Full Text] [Related]
13. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
[TBL] [Abstract][Full Text] [Related]
15. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract][Full Text] [Related]
16. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
[TBL] [Abstract][Full Text] [Related]
17. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Meaney-Delman D; Bellcross CA
Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
[TBL] [Abstract][Full Text] [Related]
18. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
19. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
20. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
